Zerr, I.

disease patient protein study creutzfeldt-jakob disease survival analysis codon creutzfeldt –jakob disease genotype level creutzfeldt-jakob prion 14-3-3 group onset duration signi table cerebrospinal fl uid mutation disease duration neurology stage number neurol result control diagnosis codon 129 position prion protein gene health university month department creutzfeldt marker polymorphism –jakob sensitivity codon 129 genotype ficant signi ficant brain signi ficantly variant cjd exposure cerebrospinal fluence prion diseases spongiform factor country tau protein germany sample value valine frequency gender fi ndings distribution 14-3-3 test concentration signi ficance association insomnia surveillance homozygote italy variant consumption cell count reference iatrogenic count allele atopic eczema spongiform encephalopathies